On Friday, February 24, 2023, the Drug Enforcement Administration (“DEA”) proposed new regulations that would permanently allow for telemedicine-controlled substance prescriptions, including induction of medication assisted therapy (“MAT”) using buprenorphine. These long-awaited rules will be subject to an accelerated, 30-day notice and comment period that ends March 31, 2023 to allow for implementation prior... READ MORE
DEA Proposes New Rules that Would Permanently Allow for Telemedicine Controlled Substance Prescriptions
Posted on February 27, 2023 in Health Law News
Published by: Hall Render
